D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Materials Science D-index 63 Citations 11,808 125 World Ranking 2659 National Ranking 662

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Gene
  • Biochemistry

His scientific interests lie mostly in Pharmacology, Nanotechnology, Nanoparticle, Drug delivery and Doxorubicin. His Pharmacology research incorporates elements of Multiple drug resistance and Chemotherapy. In the subject of general Nanotechnology, his work in Nanocapsules is often linked to Mesoporous silica and Micelle, thereby combining diverse domains of study.

His Drug delivery research includes elements of Cancer research, Liposome, Paclitaxel, Breast cancer and Drug. His Cancer research study integrates concerns from other disciplines, such as Cancer and Immunotherapy. The Doxorubicin study combines topics in areas such as Photothermal therapy, Cancer cell, Biophysics, Combination therapy and Cytotoxicity.

His most cited work include:

  • In vivo Biodistribution and Urinary Excretion of Mesoporous Silica Nanoparticles: Effects of Particle Size and PEGylation (402 citations)
  • Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking. (384 citations)
  • Current Approaches of Photothermal Therapy in Treating Cancer Metastasis with Nanotherapeutics. (339 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Cancer research, Drug delivery, Pharmacology, Metastasis and Nanotechnology. His Cancer research research includes themes of Cancer cell, Breast cancer, Metastatic breast cancer and Immunotherapy. Yaping Li interconnects Peptide, Intracellular and Drug in the investigation of issues within Drug delivery.

His work carried out in the field of Pharmacology brings together such families of science as Multiple drug resistance, In vitro, Cytotoxicity and Doxorubicin. He has included themes like Cytotoxic T cell and Immunology in his Metastasis study. His study in the fields of Nanoparticle under the domain of Nanotechnology overlaps with other disciplines such as Mesoporous silica.

He most often published in these fields:

  • Cancer research (58.57%)
  • Drug delivery (35.46%)
  • Pharmacology (24.70%)

What were the highlights of his more recent work (between 2017-2021)?

  • Cancer research (58.57%)
  • Drug delivery (35.46%)
  • Metastasis (25.90%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Cancer research, Drug delivery, Metastasis, Tumor microenvironment and Immunotherapy. Yaping Li combines subjects such as Cancer cell, Cancer immunotherapy, Prodrug, Photodynamic therapy and Cytotoxic T cell with his study of Cancer research. His Drug delivery research is multidisciplinary, incorporating perspectives in Cell, Macrophage and Chemotherapy.

His research on Metastasis also deals with topics like

  • Cytotoxicity most often made with reference to Heparan sulfate,
  • Triple-negative breast cancer which connect with Paclitaxel. As part of the same scientific family, Yaping Li usually focuses on Tumor microenvironment, concentrating on Metastatic breast cancer and intersecting with Docetaxel. His studies deal with areas such as Cancer therapy and Nanomedicine as well as Immunotherapy.

Between 2017 and 2021, his most popular works were:

  • Binary Cooperative Prodrug Nanoparticles Improve Immunotherapy by Synergistically Modulating Immune Tumor Microenvironment. (124 citations)
  • A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors. (109 citations)
  • Tumor Microenvironment-Activatable Prodrug Vesicles for Nanoenabled Cancer Chemoimmunotherapy Combining Immunogenic Cell Death Induction and CD47 Blockade. (89 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Biochemistry

Yaping Li focuses on Cancer research, Tumor microenvironment, Metastasis, Cancer cell and Immunotherapy. His biological study spans a wide range of topics, including Nanoparticle, Immune system, Drug delivery, Prodrug and Cytotoxic T cell. His research integrates issues of Internalization and Macrophage in his study of Drug delivery.

In his study, which falls under the umbrella issue of Metastasis, CTL* and Metastatic breast cancer is strongly linked to Photodynamic therapy. Yaping Li usually deals with Cancer cell and limits it to topics linked to Photothermal therapy and Stromal cell, Liposome, Extracellular matrix and Primary tumor. His research investigates the connection between Paclitaxel and topics such as Cancer stem cell that intersect with problems in Breast cancer.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking.

Xiaopin Duan;Yaping Li.
Small (2013)

535 Citations

In vivo Biodistribution and Urinary Excretion of Mesoporous Silica Nanoparticles: Effects of Particle Size and PEGylation

Qianjun He;Zhiwen Zhang;Fang Gao;Yaping Li.
Small (2011)

487 Citations

Current Approaches of Photothermal Therapy in Treating Cancer Metastasis with Nanotherapeutics.

Lili Zou;Hong Wang;Bin He;Lijuan Zeng.
Theranostics (2016)

445 Citations

Reversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumor.

Qi Yin;Jianan Shen;Zhiwen Zhang;Haijun Yu.
Advanced Drug Delivery Reviews (2013)

379 Citations

A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance.

Qianjun He;Yu Gao;Lingxia Zhang;Zhiwen Zhang.
Biomaterials (2011)

337 Citations

Controlled Intracellular Release of Doxorubicin in Multidrug-Resistant Cancer Cells by Tuning the Shell-Pore Sizes of Mesoporous Silica Nanoparticles

Yu Gao;Yu Chen;Xiufeng Ji;Xinyu He.
ACS Nano (2011)

322 Citations

Smart pH-sensitive and temporal-controlled polymeric micelles for effective combination therapy of doxorubicin and disulfiram.

Xiaopin Duan;Jisheng Xiao;Qi Yin;Zhiwen Zhang.
ACS Nano (2013)

317 Citations

The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma

Zhenghong Xu;Lingli Chen;Wangwen Gu;Yu Gao.
Biomaterials (2009)

306 Citations

Intracellular localization and cytotoxicity of spherical mesoporous silica nano- and microparticles.

Qianjun He;Zhiwen Zhang;Yu Gao;Jianlin Shi.
Small (2009)

287 Citations

Liposomes Coated with Isolated Macrophage Membrane Can Target Lung Metastasis of Breast Cancer

Haiqiang Cao;Zhaoling Dan;Xinyu He;Zhiwen Zhang.
ACS Nano (2016)

280 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Yaping Li

Jianlin Shi

Jianlin Shi

Chinese Academy of Sciences

Publications: 83

Yu Chen

Yu Chen

Shanghai University

Publications: 76

Xuesi Chen

Xuesi Chen

Chinese Academy of Sciences

Publications: 54

Xiaoyuan Chen

Xiaoyuan Chen

National University of Singapore

Publications: 47

Xian-Zheng Zhang

Xian-Zheng Zhang

Wuhan University

Publications: 46

Zhuang Liu

Zhuang Liu

Soochow University

Publications: 38

Zhongwei Gu

Zhongwei Gu

Sichuan University

Publications: 36

Jun Wang

Jun Wang

South China University of Technology

Publications: 33

Zhirong Zhang

Zhirong Zhang

Sichuan University

Publications: 32

Chengzhong Yu

Chengzhong Yu

University of Queensland

Publications: 31

Hangrong Chen

Hangrong Chen

Chinese Academy of Sciences

Publications: 30

María Vallet-Regí

María Vallet-Regí

Complutense University of Madrid

Publications: 27

Qianjun He

Qianjun He

Shenzhen University

Publications: 27

Piaoping Yang

Piaoping Yang

Harbin Engineering University

Publications: 24

Ren-Xi Zhuo

Ren-Xi Zhuo

Wuhan University

Publications: 23

Wenpei Fan

Wenpei Fan

China Pharmaceutical University

Publications: 23

Something went wrong. Please try again later.